Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 11 citing articles:

The Functional Roles of Immune Cells in Primary Liver Cancer
Linh Pham, Konstantina Kyritsi, Tianhao Zhou, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 6, pp. 826-836
Open Access | Times Cited: 27
Feasibility and safety of nivolumab in advanced hepatocellular carcinoma: real-life experience from three German centers
Fabian Finkelmeier, Carolin Czauderna, Lukas Perkhofer, et al.
Journal of Cancer Research and Clinical Oncology (2018) Vol. 145, Iss. 1, pp. 253-259
Closed Access | Times Cited: 45
Competing risk analyses of overall survival and cancer-specific survival in patients with combined hepatocellular cholangiocarcinoma after surgery
Chaobin He, Yu Zhang, Zhiyuan Cai, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 33
Neutrophil‑to‑lymphocyte ratio as a predictor of postoperative morbidity in patients with distal cholangiocarcinoma
Yusuke Kumamoto, Takashi Kaizu, Hiroshi Tajima, et al.
Molecular and Clinical Oncology (2018)
Open Access | Times Cited: 31
Clinicopathologic features, treatment, survival, and prognostic factors of combined hepatocellular and cholangiocarcinoma: A nomogram development based on SEER database and validation in multicenter study
Yuwen Zhou, Qingfang Li, Yueyun Chen, et al.
European Journal of Surgical Oncology (2022) Vol. 48, Iss. 7, pp. 1559-1566
Closed Access | Times Cited: 13
<p>Preoperative neutrophil–lymphocyte and platelet–lymphocyte ratios as independent predictors of T stages in hilar cholangiocarcinoma</p>
Hanchun Huang, Xueshuai Wan, Yi Bai, et al.
Cancer Management and Research (2019) Vol. Volume 11, pp. 5157-5162
Open Access | Times Cited: 15
Long-term outcome and prognostic factors of combined hepatocellular carcinoma and cholangiocarcinoma after curative resection
Xingxing Jiang, Xi‐Tai Huang, Chen‐Song Huang, et al.
Gastroenterology report (2020) Vol. 8, Iss. 2, pp. 134-142
Open Access | Times Cited: 14
Update on the Genetics of and Systemic Therapy Options for Combined Hepatocellular Cholangiocarcinoma
Alexander A. Azizi, Andreas V. Hadjinicolaou, Carla Gonçalves, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 14
Prognostic significance of preoperative systemic immune-inflammation index in combined hepatocellular-cholangiocarcinoma
Feng Zhang, Keshu Hu, Shenxin Lu, et al.
Cancer Biomarkers (2021), pp. 1-15
Closed Access | Times Cited: 8
Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular–cholangiocarcinoma
Tai‐Jan Chiu, Yi-Ju Chen, Fang‐Ying Kuo, et al.
PLoS ONE (2020) Vol. 15, Iss. 12, pp. e0240791-e0240791
Open Access | Times Cited: 7
Neutrophil-to-Lymphocyte Ratio: A Systemic Inflammatory Index for Primary Diagnosis and Prognosis of Cholangiocarcinoma
Sopit Wongkham
Biomedical Journal of Scientific & Technical Research (2019) Vol. 13, Iss. 2
Open Access | Times Cited: 1
Page 1

Scroll to top